Data as of 10:44am ET
| +0.2401 / +1.09%|
The 8 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 21.50, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a -3.02% decrease from the last price of 22.17.
The current consensus among 13 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.